A detailed history of Capital Planning Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Capital Planning Advisors, LLC holds 714 shares of AMGN stock, worth $202,497. This represents 0.04% of its overall portfolio holdings.

Number of Shares
714
Previous 711 0.42%
Holding current value
$202,497
Previous $222,000 3.6%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $928 - $1,012
3 Added 0.42%
714 $230,000
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $28,377 - $34,485
-108 Reduced 13.19%
711 $222,000
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $21,240 - $25,640
79 Added 10.68%
819 $232,000
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $189,218 - $213,460
740 New
740 $213,000
Q3 2021

Nov 09, 2021

SELL
$212.27 - $248.7 $175,547 - $205,674
-827 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $193,170 - $214,308
827 New
827 $202,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital Planning Advisors, LLC Portfolio

Follow Capital Planning Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning Advisors, LLC with notifications on news.